Paolo Lanzetta

University of Udine

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (8)

Enrico Borrelli

Davide Petri

Istituto Superiore di Sanità

Francesco Viola

Università degli Studi di Torino

Leopoldo Spadea

Associate Clinical Professor of Ophthalmology

Sapienza University of Rome

Daniele VERITTI

University of Udine

Roberto dell'Omo

University of Molise

Ersilia Lucenteforte

Professoressa Associata

University of Pisa

luciano quaranta

Full Professor

University of Pavia

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paolo Lanzetta

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (8)

Enrico Borrelli

Davide Petri

Francesco Viola

Leopoldo Spadea

Daniele VERITTI

Roberto dell'Omo

Ersilia Lucenteforte

luciano quaranta

Make your next move.

Paolo Lanzetta

Research Interests

Explore related searches

Contact this professor

Articles (20)

Intravitreal faricimab for diabetic macular oedema and neovascular age-related macular degeneration: general considerations and practical recommendations by an expert panel of Italian retina specialists

Intravitreal Aflibercept 8 mg in Neovascular Age-related Macular Degeneration: 96-Week Results from the Randomized Phase 3 PULSAR Trial

Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis

Plain language summary of publication of the 48-week results from the PULSAR study investigating how well a new dose of aflibercept works and how safe it is for people with wet age-related macular degeneration

Real-world evidence of anti-VEGF therapies in patients with neovascular age-related macular degeneration in Italy: The RADIANCE study

The potential role and limitations of antiseptic eyedrops in ophthalmic surgery

Extended duration of VEGF inhibition with aflibercept 8 mg: the role of reduced ocular clearance

Anti-complement intravitreal agents for geographic atrophy: A missed opportunity for European patients?

From pro-re-nata to fixed-interval regimen: evolving real-world treatment paradigms in anti-VEGF therapy for neovascular AMD

External dacryocystorhinostomy: A critical overview of the current evidence

The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey

Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose

A mini-invasive surgical technique for Carlevale IOL implantation: case series study and description of concomitant surgery

The Association between Vision Impairment and Depression: A Systematic Review of Population-Based Studies

Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers

Optical Coherence Tomography Findings in Rhegmatogenous Retinal Detachment: A Systematic Review

Single-hand preloaded intraocular lens implantation through a screw-type single use injector

Combined transconjunctival sutureless three-port vitrectomy and scleral fixation of intraocular lens

Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice

Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression

Collaborators (8)

Enrico Borrelli

Davide Petri

Francesco Viola

Leopoldo Spadea

Daniele VERITTI

Roberto dell'Omo

Ersilia Lucenteforte

luciano quaranta

Make your next move.